Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Publications indexed to the term Multiple Endocrine Neoplasia Type 2a

FacultyTitle
2Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma. (Patel D, Phay JE, Yen TWF, Dickson PV, Wang TS, Garcia R, Yang AD, Solórzano CC, Kim LT) Ann Surg Oncol 2020 May;27(5):1329-1337       64 Citations
2Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma. (Patel D, Phay JE, Yen TWF, Dickson PV, Wang TS, Garcia R, Yang AD, Kim LT, Solórzano CC) Ann Surg Oncol 2020 May;27(5):1338-1347       31 Citations
1Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. (Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG, American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma) Thyroid 2015 Jun;25(6):567-610       2162 Citations
1Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening. (Morris LF, Waguespack SG, Edeiken-Monroe BS, Lee JE, Rich TA, Ying AK, Warneke CL, Evans DB, Perrier ND, Grubbs EG) Ann Surg Oncol 2013 Jan;20(1):53-9       41 Citations
1Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A? (Grubbs EG, Waguespack SG, Rich TA, Xing Y, Ying AK, Evans DB, Lee JE, Perrier ND) Surgery 2010 Dec;148(6):1302-9; discussion 1309-10       30 Citations
1Efficacy of 4D-CT preoperative localization in 2 patients with MEN 2A. (Philip M, Guerrero MA, Evans DB, Hunter GJ, Edeiken-Monroe BS, Vu T, Perrier ND) J Surg Educ 2008;65(3):182-5       14 Citations
1Atypical presentation of pheochromocytoma as part of multiple endocrine neoplasia IIa in pregnancy. (Ahn JT, Hibbard JU, Chapa JB) Obstet Gynecol 2003 Nov;102(5 Pt 2):1202-5       15 Citations
1The role of genetics in the surgical management of familial endocrinopathy syndromes. (Shapiro SE, Cote GC, Lee JE, Gagel RF, Evans DB) J Am Coll Surg 2003 Nov;197(5):818-31       27 Citations
1Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. (Yip L, Cote GJ, Shapiro SE, Ayers GD, Herzog CE, Sellin RV, Sherman SI, Gagel RF, Lee JE, Evans DB) Arch Surg 2003 Apr;138(4):409-16; discussion 416       205 Citations
1Noncardiogenic pulmonary edema as the chief manifestation of a pheochromocytoma: a case report of MEN 2A with pedigree analysis of the RET proto-oncogene. (Okada Y, Suchi M, Takeyama H, Hodgson ME, Kato T, Manabe T) Tohoku J Exp Med 1999 Jun;188(2):177-87       8 Citations
1The surgical treatment of medullary thyroid carcinoma. (Evans DB, Fleming JB, Lee JE, Cote G, Gagel RF) Semin Surg Oncol 1999;16(1):50-63       61 Citations
1Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. (Lee JE, Curley SA, Gagel RF, Evans DB, Hickey RC) Surgery 1996 Dec;120(6):1064-70; discussion 1070-1       185 Citations
1Clinical presentations and RET protooncogene mutations in seven multiple endocrine neoplasia type 2 kindreds. (Blank RD, Sklar CA, Dimich AB, LaQuaglia MP, Brennan MF) Cancer 1996 Nov 01;78(9):1996-2003       30 Citations
1Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. (Wohllk N, Cote GJ, Bugalho MM, Ordonez N, Evans DB, Goepfert H, Khorana S, Schultz P, Richards CS, Gagel RF) J Clin Endocrinol Metab 1996 Oct;81(10):3740-5       203 Citations
1Denaturing gradient gel electrophoresis to diagnose multiple endocrine neoplasia type 2. (Blank RD, Sklar CA, Martin ML) Clin Chem 1996 Apr;42(4):598-603       11 Citations
1Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. (Wohllk N, Cote GJ, Evans DB, Goepfert H, Ordonez NG, Gagel RF) Endocrinol Metab Clin North Am 1996 Mar;25(1):1-25       61 Citations
1Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A. (Gagel RF, Cote GJ, Martins Bugalho MJ, Boyd AE 3rd, Cummings T, Goepfert H, Evans DB, Cangir A, Khorana S, Schultz PN) J Intern Med 1995 Oct;238(4):333-41       68 Citations